INTRODUCTION
Hepatoid adenocarcinoma is a special type of extrahepatic adenocarcinoma that mimics hepatocellular carcinoma morphologically and immunohistochemically, and also shares the alpha-fetoprotein (AFP) producing feature (1) . Because of the poor prognosis of this histologic tumor type, accurate diagnosis of hepatoid adenocarcinoma is important for developing the treatment plan. Hepatoid adenocarcinomas have been reported in various organs, including esophagus, stomach, colon, pancreas, gall bladder, lung, urinary bladder, ovaries and uterus (2) (3) (4) (5) (6) .
Among them, imaging findings of hepatoid adenocarcinomas of the stomach have been reported in a large series to date (2) .
With respect to hepatoid adenocarcinoma of the small bowel, only two cases have been reported in patients with long-standing Crohn's disease (6, 7) . In addition, to the best of our knowledge, there is no report describing the radiologic features of hepatoid adenocarcinoma of the small bowel in a patient who did not have inflammatory bowel disease or other risk factors.
We describe a case of hepatoid adenocarcinoma of the jejunum with hepatic metastases that developed in a patient who did not have any risk factors for small bowel cancer and discuss the imaging features in terms of dynamic CT and small bowel followthrough.
CASE REPORT
A 48-year-old man was referred to our hospital for evaluation of a huge hepatic tumor that was detected during abdominal sonographic examination at an outside hospital.
On physical examination, the patient appeared to be acutely ill with a blood pressure of 135/80 mm Hg, heart rate of 75 beats/ min and temperature of 37°C. He had no remarkable previous medical history including viral hepatitis or chronic alcoholism.
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Index terms
His serum was positive for hepatitis B surface antibody, but negative for hepatitis B surface antigen and anti-HCV.
The radiograph of the abdomen showed no detectable abnormality. We performed dynamic CT to evaluate the liver mass and CT images revealed multiple heterogeneously and peripherally enhanced masses in both lobes of the liver. These masses showed persistent and more enhancement in the portal and delayed phases than in the arterial phase (Fig. 1A) . The largest tumor was a 14 × 12 cm-sized mass, comprised of a central high density (56 Hounsfield units) area on the pre-contrast scan without gross contrast enhancement, suggesting hemorrhage or necrosis. Cirrhotic change in the liver was not observed. Also, CT scans showed 6.5 cm-long eccentric irregular enhancing wall thickening and perilesional infiltration in the proximal jejunum.
Several adjacent lymph nodes were enlarged (up to 4 cm) with some internal low attenuation (Fig. 1B) . Double contrast small bowel follow-through was performed to evaluate the small bowel lesion, and it showed a short, circumferentially narrowed segment with irregular mucosal disruption and ulcer in the proximal jejunum (Fig. 1C) . We suggested small bowel adenocarcinoma of the jejunum, metastatic regional lymph node enlargement, and multiple hepatic metastases. On the positron emission tomography image, multiple focal strong fluorodeoxyglucose (FDG) uptakes, a 10 cm-sized well-defined mass in the liver, and focal small bowel wall thickening with strong focal FDG uptake (standardized uptake value = 6.25) were noted (Fig. 1D) .
The surgeon performed segmental resection of the proximal jejunum and biopsy of the liver mass to confirm the tumor origin, to determine the treatment option, and to relieve the symptoms of small bowel obstruction. The gross pathology of the proximal jejunum showed an irregular transluminal mass with infiltration and enlarged regional lymph nodes (Fig. 1E) . Hematoxylin and eosin staining of the tumor cells from the proximal jejunum revealed clear cell cytoplasm which is a more prevalent finding in hepatoid adenocarcinoma than in adenocarcinoma. Immunohistochemical staining of the tumor cells from the jejunum with hepatocyte specific antigen and polyclonal Fig. 1 . A 48-year-old man with a liver mass detected on ultrasonography. B. Coronal reformatted post contrast enhanced CT scan shows an irregular mass in the proximal jejunum (arrows), enlarged regional lymph nodes (arrowheads), and a huge liver mass (curved arrows). C. Small bowel follow-through shows a focal luminal mass with shouldering and irregular mucosal destruction (arrows). D. PET shows multiple focal strong FDG uptakes in both lobes with a large FDG defect lesion (curved arrow) in the right lobe of the liver and focal and marked wall thickening of the small bowel (arrow) with strong FDG uptake. E. Gross specimen shows a huge, ill-defined, ulcerated mass (arrow), measuring about 8 × 10 cm and multiple enlarged lymph node (arrowheads) with a necrotic surface. Instead of the arterial wash-in and delayed wash-out pattern, delayed peripheral enhancement was noted just like in usual hepatic metastases. Considering these imaging findings, our case of hepatoid adenocarcinoma is more prone to metastasis than hepatocellular carcinoma (9, 10) . Like in other articles (2-5), our case of hepatoid adenocarcinoma also showed aggressive behavior due to extensive hepatic metastases and metastatic lymphadenopathy.
In conclusion, we report a case of hepatoid adenocarcinoma 
